Abstract PWE-133 Table 1
AetiologyNumberOGD within 3 years (%)Indication (%)
Screening/ surveillanceBleedingOther
Alcohol6751 (76.1)37 (55.2)9 (13.4)5 (7.5)
NAFLD/NASH85 (62.5)3 (37.5)1 (12.5)1 (12.5)
Other*87 (87.5)5 (62.5)1 (12.5)1 (12.5)
  • * autoimmune hepatitis, primary biliary cirrhosis, hepatitis C, cryptogenic cirrhosis, and unknown or still under investigation